
Ensign Peak Advisors’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $255M | Buy |
2,297,702
+152,685
| +7% | +$16.9M | 0.44% | 46 |
|
2025
Q1 | $240M | Buy |
2,145,017
+475,146
| +28% | +$53.2M | 0.46% | 44 |
|
2024
Q4 | $154M | Buy |
1,669,871
+60,474
| +4% | +$5.59M | 0.27% | 73 |
|
2024
Q3 | $135M | Buy |
1,609,397
+180,559
| +13% | +$15.1M | 0.24% | 87 |
|
2024
Q2 | $98M | Sell |
1,428,838
-4,940
| -0.3% | -$339K | 0.18% | 104 |
|
2024
Q1 | $105M | Sell |
1,433,778
-1,545,570
| -52% | -$113M | 0.19% | 106 |
|
2023
Q4 | $241M | Sell |
2,979,348
-599,352
| -17% | -$48.6M | 0.48% | 48 |
|
2023
Q3 | $268M | Sell |
3,578,700
-62,976
| -2% | -$4.72M | 0.57% | 38 |
|
2023
Q2 | $281M | Buy |
3,641,676
+66,002
| +2% | +$5.09M | 0.57% | 37 |
|
2023
Q1 | $297M | Sell |
3,575,674
-384,720
| -10% | -$31.9M | 0.64% | 34 |
|
2022
Q4 | $340M | Sell |
3,960,394
-524,375
| -12% | -$45M | 0.77% | 27 |
|
2022
Q3 | $277M | Buy |
4,484,769
+1,790,559
| +66% | +$110M | 0.69% | 35 |
|
2022
Q2 | $167M | Buy |
2,694,210
+489,240
| +22% | +$30.2M | 0.4% | 69 |
|
2022
Q1 | $131M | Buy |
2,204,970
+650,488
| +42% | +$38.7M | 0.27% | 88 |
|
2021
Q4 | $113M | Sell |
1,554,482
-432,547
| -22% | -$31.4M | 0.22% | 103 |
|
2021
Q3 | $139M | Sell |
1,987,029
-132,383
| -6% | -$9.25M | 0.29% | 89 |
|
2021
Q2 | $146M | Buy |
2,119,412
+272,079
| +15% | +$18.7M | 0.29% | 89 |
|
2021
Q1 | $119M | Buy |
1,847,333
+271,021
| +17% | +$17.5M | 0.26% | 98 |
|
2020
Q4 | $91.8M | Buy |
1,576,312
+519,718
| +49% | +$30.3M | 0.21% | 112 |
|
2020
Q3 | $66.8M | Sell |
1,056,594
-197,800
| -16% | -$12.5M | 0.17% | 116 |
|
2020
Q2 | $96.5M | Sell |
1,254,394
-244,281
| -16% | -$18.8M | 0.26% | 78 |
|
2020
Q1 | $112M | Buy |
1,498,675
+623,260
| +71% | +$46.6M | 0.38% | 62 |
|
2019
Q4 | $56.9M | Buy |
+875,415
| New | +$56.9M | 0.15% | 115 |
|